Axelsson, K. F.
Litsne, H.
Lorentzon, M.
Funding for this research was provided by:
Vetenskapsrådet
Sahlgrenska Universitetssjukhuset
University of Gothenburg
Article History
Received: 12 February 2021
Accepted: 12 July 2021
First Online: 26 August 2021
Change Date: 10 November 2021
Change Type: Update
Change Details: The original version was revised due to an update in the funding note.
Declarations
:
: Dr. Axelsson has received lecture fees from Lilly, Meda/Mylan, and Amgen. Prof. Lorentzon has received lecture fees from Astellas, Amgen, Lilly, UCB Pharma, Radius Health, Meda/Mylan, GE-Lunar, and Santax Medico/Hologic. Mr Litsne has no conflict of interest.